Warfarin Sodium

Determinants of Warfarin Metabolism

START-Register: Survey on Anticoagulated Patients Register

Assessment of TRanscathetEr and Surgical Aortic BiOprosthetic Valve Thrombosis and Its TrEatment With Anticoagulation

Partners Calciphylaxis Biobank

Implementation of Point-of-Care Pharmacogenomic Decision Support Accounting for Minority Disparities

Low INR to Minimize Bleeding With Mechanical Valves Trial

The Danish Warfarin-Dialysis Study - Safety and Efficacy of Warfarin in Patients With Atrial Fibrillation on Dialysis

Long-term Anticoagulation With Oral Factor Xa Inhibitor Versus Vitamin K Antagonist After Mechanical Aortic Valve Replacement

The Direct Oral Anticoagulation Versus Vitamin K Antagonist After Cardiac Surgery Trial

Study of Predictive Factors Related to Prognosis of Patients With Ischemic Stroke Due to Large-artery Atherosclerosis

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Left Atrial Appendage Closure in Patients With Non-valvular Atrial Fibrillation and End-stage Chronic KIDNEY Disease

LAAO Versus NOAC in Patients with AF and PCI

Rivaroxaban for Children Aged Over 2 Years With Giant Coronary Artery Aneurysms After Kawasaki Disease

Registry on Augmented Antithrombotic Treatment Regimens for Patients With Arterial Thrombotic APS

DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis

Antithrombotic Therapy After Coronary Artery Bypass Grafting Combined With Coronary Endarterectomy

Anticoagulation in Post MI LV Thrombus Trial in Nepal

Long-Term Outcomes of LAA Contrast Flow in CT Scans After Endocardial LAA Closure: The CF-CT Registry

Can Patients With Atrial Fibrillation Safely Discontinue Anticoagulant Therapy After Cardiac Surgery? (ATLAAC)

Vitamin K AntagonISt, Factor Xa Inhibitor or No Anticoagulation in Atrial Fibrillation and DIalytic End-stage Renal DiseasE (VISIONAIRE)

International Care Bundle Evaluation in Cerebral Hemorrhage Research

Treatment With Apixaban Versus Warfarin in Patients With Left Ventricular Thrombus After Acute Myocardial Infarction

Discontinuation of Anticoagulations After Successful Catheter Ablation of Atrial Fibrillation

Aspirin and Hemocompatibility Events in Chronic Advanced Heart Failure Patients With Assist Device

Restarting Early Versus Later Anticoagulation for Chronic Subdural Hematoma With Atrial Fibrillation

Safety and Effectiveness of Early Aspirin Administration After Mitral Valve Repair

Perioperative Anticoagulant Use for Surgery Evaluation -Virtual Visit (PAUSE-Virtual)

Real-World Study of PADN for the Treatment of PAH

Study on Gastric Emptying Effect and Drug-Drug Interactions of GZR18 Injection

A Drug-Drug Interaction Study of HDM1002 and Metformin, Empagliflozin, Midazolam, Valsartan, and Warfarin

Colchicine Treatment for Non-Flow-Limiting Coronary Plaque by Coronary CTA: A Randomized Controlled Trial

Randomized Trial of Anticoagulation Plus Batroxobin for Acute Cerebral Venous Thrombosis

Rivaroxaban in Idiopathic Membranous Nephropathy

Comparison of Anti-Thrombotic Treatments Between Aspirin and Warfarin During Initial Six Months After Bioprosthetic Heart Valve Replacement

Catheter Ablation Plus LAAO Versus Anticoagulation in Frail Elderly Patients With Atrial Fibrillation

Vitamin K for Perioperative Warfarin Management

MENA Regional Endovascular Intervention for Venous Cerebral Venous Sinus Thrombosis

Optimizing Anticoagulation in Pregnancies With Mechanical Heart Valves

An Early-Stage Study in Multiple Clinics of How Afimkibart May Affect the Body's Processing of Medicines That Rely on Cytochrome P450 Enzymes in Participants With Ulcerative Colitis

Aspirin Monotherapy Versus Sequential Warfarin-Aspirin Therapy After TAVR in Patients With Pure Aortic Regurgitation

Apixaban Versus Warfarin for Left Ventricular Thrombus

A Research Study on How UBT251 Affects Levels of Midazolam, Caffeine and Warfarin in the Blood of Participants With Excess Body Weight

Phase I Drug-Drug Interaction Study of UBT251 Injection in Participants With Overweight or Obesity

A Study on Abnormal Menstrual Bleeding in Chinese Women of Childbearing Age Taking Antithrombotic Drugs After Cardiovascular Surgery

Post Coronary Artery Bypass Graft (CABG) Study

Boston Area Anticoagulation Trial for Atrial Fibrillation (BAATAF)

Arterial Disease Multifactorial Intervention Trial (ADMIT)

Prevention of Recurrent Venous Thromboembolism (PREVENT)

Treatment for Blood Clots in the Veins of the Legs

Hormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Prostate Cancer

Aspirin Or Warfarin To Prevent Stroke

Oral Anticoagulant Therapy for Venous Thrombosis - SCOR in Thrombosis

Warfarin and Antiplatelet Therapy in Chronic Heart Failure

Combination Chemotherapy Plus Warfarin in Treating Patients With Prostate Cancer

Warfarin in Preventing Blood Clots in Cancer Patients With Central Venous Catheters

Warfarin Versus Aspirin Recurrent Stroke Study

Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial

SR34006 Compared to Vitamin K Antagonist (VKA) in the Treatment of Pulmonary Embolism

Evaluating the Use of SR34006 Compared to Warfarin or Acenocoumarol in Patients With Atrial Fibrillation (AMADEUS)

Following Patients on Warfarin Therapy to See if Differences in Hemorrhagic Complications Exist

Warfarin and Vatalanib in Treating Patients With Advanced Solid Tumors

BMS-562247 in Subjects Undergoing Elective Total Knee Replacement Surgery

Warfarin and Antiplatelet Vascular Evaluation

WATCHMAN Left Atrial Appendage System for Embolic PROTECTion in Patients With Atrial Fibrillation

Oral Vitamin K for Warfarin Associated Coagulopathy

Access II - Trial of Warfarin to Prevent Malfunction of Haemodialysis Catheters

Relationship Between Folic Acid and Warfarin Metabolism and Effect

Genetic Determinants of Warfarin Anticoagulation Effect

Anticoagulation in Liver Fibrosis in Patients With Hepatitis C Virus Infection

International Multi Centre Randomized Clinical Trial Of Anticoagulation In Children Following Fontan Procedures

Evaluation of the STARFlex® Septal Closure System in Patients With a Stroke or TIA Due to the Possible Passage of a Clot of Unknown Origin Through a Patent Foramen Ovale (PFO)

Trial of the Effect of Low-Molecular-Weight Heparin (LMWH) Versus Warfarin on Mortality in the Long-Term Treatment of Proximal Deep Vein Thrombosis (DVT) (Main LITE Study)

Assessment of Long-Term Out-of-Hospital Treatment of Patients With Proximal Deep Vein Thrombosis (DVT) Using Low-Molecular-Weight Heparin (LMWH) Versus LMWH Followed by Warfarin

Long Term Open Follow-up With H376/95 vs. Warfarin

The Catheter Study: Central Venous Catheter Survival in Cancer Patients Using Low Molecular Weight Heparin (Dalteparin) for the Treatment of Deep Vein Thrombosis

Aortic Arch Related Cerebral Hazard Trial (ARCH)

To Determine the Feasibility of a Clinical Trial Comparing Anticoagulants Versus Antiplatelets in the Acute Treatment of Patients With Cervical Artery Dissection

Odiparcil For The Prevention Of Venous Thromboembolism

Treatment of Upper Extremity Deep-Vein Thrombosis

The Association of Warfarin Dosage and Plasma Enantiomer Concentration With the Gene Polymorphisms of CYP and VKOR

Patients Preference With Self-Injection: The PRISM Study

A Comparison of Dalteparin and Tinzaparin for Prevention of Blood Clots in Hemodialysis Patients on Oral Anticoagulants Having Surgery

Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate

Pilot Study of Aspirin Versus Warfarin for Cervicocephalic Arterial Dissection

Daily Vitamin K in Patients on Warfarin With Unstable INRs

Comparison Between Point of Care Device and Venous Blood International Normalized Ratio Measurements.

Efficacy and Safety of Dabigatran Compared to Warfarin for 6 Month Treatment of Acute Symptomatic Venous Thromboembolism

Randomized On-X Anticoagulation Trial

ABRIDGE: Low Molecular Weight Heparin in Bridging Patients After Mechanical Valve Replacement

LV Thrombus Pilot Study for Comparing Enoxaparin Vs. Warfarin

Secondary Prevention of Venous Thrombo Embolism (VTE).

A Pharmacogenetic Study of Warfarin Dosing, "The COUMA-GEN Study"

Clinical Study Assessing Idrabiotaparinux Sodium Injections Once-weekly in Pulmonary Embolism Therapeutic Approach

Prolongation of the Interval Between Monitoring of Warfarin in Stable Patients

3 Months' Versus 6 Months' Anticoagulation in Patients With DVT and/or PE

PRospective Evaluation Comparing Initiation of Warfarin StrategiEs (PRECISE): Pharmacogenetic-guided Versus Usual Care

Ultrasound Findings to Adjust the Duration of Anticoagulation

Study to Develop a Reliable Nomogram That Incorporates Clinical and Genetic Information

A Study To Test The Effect Of GW786034 (Pazopanib) On P450 Enzymes

An Efficacy and Safety Study of Rivaroxaban With Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Patients With Non-Valvular Atrial Fibrillation

A Study Testing the Effect and Safety of Casopitant (GW679769) While Taking Warfarin in Healthy Human Volunteers

Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation

D-dimer to Predict Recurrence in Patients With Multiple Episodes of Venous Thromboembolism

PERIOP 2 - A Safety and Effectiveness of LMWH vs Placebo Bridging Therapy for Patients on Long Term Warfarin Requiring Temporary Interruption of Warfarin.

Residual Vein Thrombosis Establishes the Optimal Duration of Oral Anticoagulants

Direct Factor Xa Inhibitor YM150 for Prevention of Stroke in Subjects With Non-Valvular Atrial Fibrillation

Evaluate the Effects of Patupilone on the Pharmacokinetics and Pharmacodynamics of Warfarin in Patients With Advanced Malignancies

Safety and Efficacy Study of GM-CSF, Thalidomide Plus Docetaxel in Prostate Cancer

Transcranial Doppler (TCD) Assessment During Early Anti-thrombotic Therapy After Bioprosthetic Aortic Valve Replacement

Patent Foramen Ovale Closure or Medical Therapy After Stroke - RESPECT Trial

The Effects of Patupilone on the Pharmacokinetics and Pharmacodynamics of Warfarin in Patients With Advanced Malignancies

Anticoagulant Therapy During Pacemaker Implantation

Modeling Genotype and Other Factors to Enhance the Safety of Coumadin Prescribing

Interaction Between ABT-335, Rosuvastatin and Warfarin

Efficacy and Safety of Rivaroxaban for the Prevention of Stroke in Subjects With Non-Valvular Atrial Fibrillation

A Study to Assess the Safety of a Potential New Drug in Comparison to the Standard Practice of Dosing With Warfarin for Non-valvular Atrial Fibrillation

Comparison of Warfarin Dosing Using Decision Model Versus Pharmacogenetic Algorithm

Lovaza's Effect on the Activation of Platelets

Bortezomib and Dexamethasone With or Without Lenalidomide in Treating Patients With Multiple Myeloma Previously Treated With Dexamethasone

Standard Drug Therapy vs. Implanted Defibrillator for Primary Prevention of Sudden Cardiac Death

Duloxetine - Warfarin Pharmacodynamic Study

Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk

The Safety of Cataract Removal by Phacoemulsification Surgery in Patients Under Anti-aggregant and Coumadin Treatment

Evaluation of Weekly Idrabiotaparinux Sodium Versus Oral Adjusted-dose Warfarin to Prevent Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation

Patient Self Testing of Warfarin Therapy

A Study to Evaluate the Safety and Efficacy of YM150 in Patients With Knee Replacement Surgery

Pharmacodynamic Drug Interaction Between Warfarin and Amoxicillin-clavulanic Acid

Effects of LMWH in Healthy Subjects Treated With TB-402 and Effects of TB-402 in Healthy Subjects Treated With Warfarin

Prevention of Venous Thrombosis After Permanent Transvenous Leads Implantation

Testing Strategies to Improving Warfarin Adherence

Absence of Residual Vein Thrombosis Permits to Withdrawn Oral Anticoagulants

Prospective Genotyping For Total Hip or Knee Replacement Patients Receiving Warfarin (Coumadin)

Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism

Long-term Safety in Atrial Fibrillation Patients

Pharmacogenetic Study of Warfarin Dose-Response: a Prospective Trial

Comparison of Point of Care to Lab INR in Dialysis Patients on Warfarin

Warfarin After Anterior ST-Elevation Myocardial Infarction

The Relationship Between Osteoporosis and Chronic Oral Anticoagulation Therapy With Warfarin

Fondaparinux for the Treatment of Heparin-Induced Thrombocytopenia (HIT)

Phase III Study Testing Efficacy & Safety of Oral Dabigatran Etexilate vs Warfarin for 6 m Treatment for Acute Symp Venous Thromboembolism (VTE)

Enhancing the Safety of Warfarin in Nursing Homes

Effect of Warfarin in the Treatment of Metachromatic Leukodystrophy

Prevention of Stroke and Systemic Embolic Events in Patients With Atrial Fibrillation

Drug Interaction Study Between AZD3480 and Warfarin

Comparison of ATI-5923, a Novel Vitamin K Antagonist, With Warfarin in Patients Requiring Chronic Anticoagulation

Patent Foramen Ovale in Cryptogenic Stroke Study

Assessing the Clinical Benefits of a Pharmacogenetics-Guided Dosing Regiment for Calculating Warfarin Maintenance Dose

Randomized Study of the Use of Warfarin During Pacemaker or ICD Implantation in Patients Requiring Long Term Anticoagulation

Ongoing WARfarin and Coronary STENTing

Drug Interaction Study With a Potential Alzheimer's Disease Compound

Does Anticoagulant Control Change Following Referral Back to the Primary Care Physician?

Prolonged Anticoagulation After a First Episod of Idiopathic Proximal Deep Vein Thrombosis (PADIS TVP)

Extended Duration of Oral Anticoagulant Therapy After a First Episode of Idiopathic Pulmonary Embolism: a Randomized Controlled Trial. "PADIS-PE" Study.

Phase 2 Study of the Safety, Tolerability and Pilot Efficacy of Oral Factor Xa Inhibitor Betrixaban Compared to Warfarin

Prophylaxis Against DVTs After Primary Hip and Knee Replacement Surgery

Factor VII, Prothrombin Complex Concentrate, and Fresh Frozen Plasma in Warfarin-Related Intracranial Hemorrhage

Triple Therapy in Patients on Oral Anticoagulation After Drug Eluting Stent Implantation

Drug Interaction Study of Rifampin and Warfarin in Healthy Volunteers.

Global Study to Assess the Safety and Effectiveness of Edoxaban (DU-176b) vs Standard Practice of Dosing With Warfarin in Patients With Atrial Fibrillation

Effectiveness of Bridging Anticoagulation for Surgery (The BRIDGE Study)

A Phase 2 Study To Evaluate The Safety Of Apixaban In Atrial Fibrillation

Predicting Bleeding Risk on Anticoagulant Therapy for Venous Thromboembolism

Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis

Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction

Low Dose Supplementation to Improve Anticoagulation Control With Oral Vitamin K as an Adjuvant to Warfarin Therapy

Bridge or Continue Coumadin for Device Surgery Randomized Controlled Trial

DU-176b Phase 2 Dose Finding Study in Subjects With Non-valvular Atrial Fibrillation

Prothrombin Times Outside the Therapeutic Range in Otherwise Stable Patients

A Phase 1, Randomized, Open-Label, Two-Way Crossover Study To Evaluate The Steady-State Effect Of Dimebon (PF 01913539) On The Single-Dose Pharmacokinetics And Pharmacodynamics Of Warfarin In Healthy Subjects

Late Phase 2 Study of DU-176b in Patients With Non-Valvular Atrial Fibrillation

The Clinical and Economic Impact of Pharmacogenomic Testing of Warfarin Therapy in Typical Community Practice Settings

Clarification of Optimal Anticoagulation Through Genetics

ASA Plavix Feasibility Study With WATCHMAN Left Atrial Appendage Closure Technology

A Clinical Study to Determine the Effect of YM178 on the Pharmacokinetics of Warfarin in Healthy Subjects

Warfarin and Coronary Calcification Project

Computer Stop Order Alert to Prevent Concurrent Prescribing of Trimethoprim/Sulfamethoxazole and Warfarin

Personalized Warfarin Dosing by Genomics and Computational Intelligence

Reliability of Point-of-care INR Measurements in Patients With Antiphospholipid-antibody Syndrome Treated With Warfarin

Warfarin and Non-Steroidal Anti-Inflammatory Drugs (NSAID) Customized Alert

D-Dimer Guided Oral Anticoagulant Treatment (OAT)

Study of the Effect of Dapagliflozin on the Pharmacokinetics of Warfarin or Digoxin in Healthy Subjects

Genotype-Guided Warfarin Therapy Trial

Randomized Trial of Interventions to Improve Warfarin Adherence

Predictors of Anticoagulation Control on Warfarin Therapy

Comparing Different Routes and Doses of Phytonadione (Vitamin K) for Reversing Warfarin Treated Patients With Hip Fracture Before Surgery

Feasibility Study of Exercise in Patients With Leg Blood Clots

The Effect Of Fesoterodine On Pharmacokinetics And Pharmacodynamics Of Warfarin In Healthy Subjects

Warfarin Patient Self-Monitoring

Applying Pharmacogenetic Algorithms to Individualize Dosing of Warfarin

International Normalized Ratio (INR) Normalization in Coumadin Associated Intracerebral Haemorrhage

A Clinical Trial to Evaluate the Effect of Fimarsartan on Pharmacodynamics, Pharmacokinetics, and the Safety of Warfarin in Healthy Male Volunteers

A Study Evaluating Safety and Tolerability of YM150 Compared to Warfarin in Subjects With Atrial Fibrillation

The Safety of Hand Surgery in the Anticoagulated Patient

AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis

Clinical and Economic Implications of Genetic Testing for Warfarin Management

Anticoagulant Clinics and Vitamin K Antagonists

VKORC1 and CYP2C9 Gene Polymorphisms and Warfarin Management

BAY59-7939 in Atrial Fibrillation Once Daily (OD)

BAY59-7939 Japanese in Atrial Fibrillation (2nd)

Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study).

Does Low Dose Oral Vitamin K Improve International Normalized Ratio (INR) Stability?

Personalized Medicine Interface Tool (PerMIT): Warfarin: A Trial Comparing Usual Care Warfarin Initiation to PerMIT Pharmacogenetic Guided Warfarin Therapy

A Pharmacokinetic Study of RO5185426 in Combination With a Drug Cocktail in Patients With Metastatic Melanoma

Outcomes of an Anticoagulation Clinic in an University Hospital

Genetics Informatics Trial (GIFT) of Warfarin to Prevent DVT

Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation

Simple Warfarin Dosing Algorithm Study

BIIB014 Effects on the Pharmacokinetics (PK) of Rosiglitazone, Warfarin, and Midazolam

Anticoagulant and Antiplatelet Agents in Patients Undergoing Vitreoretinal Surgery

The Potential for Oral Diindolylmethane (DIM) Supplementation to Increase the Production of the BRCA1 Protein in BRCA1 Mutation Carriers

Randomized Comparison of Warfarin Dosing Quality Between the Hamilton Nomogram and a Commercial Computer System

Quality of Life and Efficacy Evaluation of Patient Self-monitoring Their Oral Anticoagulation Therapy

Mechanisms Underlying Drug-Diet Interactions

Anticoagulation For Pulmonary Hypertension in Sickle Cell Disease

Safer Warfarin Treatment

Bendamustine in Combination With Lenalidomide and Dexamethasone in Refractory or Relapsed Multiple Myeloma

Study of Genetic Factors Other Than CYP2C9 and VKORC1 That Influence Warfarin Dose Requirements in a South-east Asian Population

Warfarin - How Good Are we at Maintaining Target Range ?

Study the Effect of Avanafil on the Pharmacodynamics and Pharmacokinetics of Warfarin in Healthy Male Subjects

Investigate the Effect of AZD1656 on the Pharmacokinetics and Pharmacodynamics of Warfarin in Type 2 Diabetes Mellitus (T2DM) Patients

Drug Interaction Between Paracetamol and Warfarin

Drug Drug Interaction of Empagliflozin (BI 10773) and Warfarin in Healthy Volunteers

AMPLATZER Cardiac Plug Clinical Trial

EUropean Pharmacogenetics of AntiCoagulant Therapy - Warfarin

Evaluation of Maintenance Dosing vs Loading Dosing Upon Restarting Warfarin Therapy: A Prospective Randomized Trial

Long-Term Innohep® Treatment Versus a Vitamin K Antagonist (Warfarin) for the Treatment of Venous Thromboembolism (VTE) in Cancer

A Study to Determine the Effects of Multiple Doses of Mipomersen (200 mg SC) on the Pharmacodynamics and Pharmacokinetics of Single-dose Warfarin

A Dose Response Study of Dabigatran Etexilate(BIBR 1048) in Pharmacodynamics and Safety in Patients With Non-valvular Atrial Fibrillation in Comparison to Warfarin

A Drug Interaction Study With Albiglutide and Warfarin

Long-term Treatment for Cancer Patients With Deep Venous Thrombosis or Pulmonary Embolism

Early Identification of Warfarin Maintenance Dosage

PGx Study to Develop and Validate the Predictive Warfarin Dosing Algorithm for Personalized Warfarin Pharmacotherapy

Drug-Drug Interaction Study to Assess the Effects of Steady State Pitavastatin 4 mg or Rosuvastatin 40 mg on Steady-State Warfarin in Healthy Adult Volunteers

Evaluation of the WATCHMAN Left Atrial Appendage (LAA) Closure Device in Patients With Atrial Fibrillation Versus Long Term Warfarin Therapy

A Drug Interaction Study of Warfarin and Canagliflozin in Healthy Adult Volunteers

Evaluation of the Next Generation WATCHMAN LAA Closure Technology in Non-Valvular AF Patients (EVOLVE)

A Drug-Drug Interaction Study to Study the Effect of AZD1981 on Warfarin

A Drug-Drug Interaction Study Between AZD9668 and Warfarin to Study the Effect of AZD9668 on the Metabolism and Effect of Warfarin

PETRO Stroke Prevention in Patients With AF by Treatment With Dabigatran, With and Without Aspirin, Compared to Warfarin

Significance of Antibodies to Heparin/Platelet Factor 4 Complex in Vein Graft Patency and Potential Role of Argatroban for Prevention of Vein Graft Occlusion

Human Cytochrome P450 4F Enzymes and Drug Interactions

A Study of LY2216684 and Warfarin in Healthy Subjects

Optimal Duration of Anticoagulation in Deep Venous Thrombosis

BAY73-4506 Probe Substrate Study

Warfarin Adverse Event Reduction For Adults Receiving Genetic Testing at Therapy INitiation (WARFARIN)

Effects of Administration of Fostamatinib on Blood Concentrations of Warfarin in Healthy Subjects

A Study of Belinostat in Combination With Warfarin in Patients With Solid Tumors or Hematological Malignancies

Pharmacogenetics of Warfarin in Puerto Ricans.

Transjugular Intrahepatic Portosystemic Shunt (TIPS) for Prevention of Variceal Rebleeding in Cirrhotic Patients With Portal Vein Thrombosis

Education Program for Patients Receiving Oral Anticoagulation

A Pharmacokinetics Study of the Effects of GSK2118436 on Warfarin, the Effects of Ketoconazole and Gemfibrozil on GSK2118436, and the Effects of Repeat Doses of GSK2118436 in Subjects With BRAF Mutant Solid Tumors

Reinitiation of Anticoagulation After Temporary Withdrawal of Vitamin K Antagonist

Evaluating of CREATIF an Anti-coagulation Clinic

Study to Test the Accuracy of a Prototype Handheld PT/INR Device

Study to Determine the Accuracy of Prothrombin Time of Warfarinised Blood

Genetic Variability in the Response to Warfarin at Baseline and During Induction of CYP2C9

A Drug Interaction Study to Assess the Effect of LY317615 on the Metabolic Pathway of Warfarin

Sunitinib or Cediranib for Alveolar Soft Part Sarcoma

A Study to Explore the Pharmacodynamic Changes When Transitioning From Rivaroxaban to Warfarin in Healthy Volunteers

Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care

Interaction of Epanova on Warfarin Pharmacokinetic and Anticoagulant Activity and Comparison of the Effects of Epanova and Lovaza on Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) After Low-fat Meals

A Study of the Effect of Dulaglutide on the Action of Warfarin in Healthy Participants

The Effect and Safety of Different Intensity Anticoagulation Therapy in Elderly Patients With Non-valvular Atrial Fibrillation

Pharmacogenetics of Warfarin Induction and Inhibition

Dabigatran Etexilate in Patients With Mechanical Heart Valves

Anticoagulant After Implantation of Biological Aortic Valve Comparing With Aspirin

An Open-Label Immunogenicity and Pharmacokinetics Study of Daclizumab High Yield Process Prefilled Syringe in Relapsing Remitting Multiple Sclerosis

Use of Phytonadione to Reduce International Normalized Ratio (INR) Variability in Patients on Long-term Warfarin Therapy

A Study to Evaluate the Effect of T89(Dantonic®)on Steady-State Pharmacodynamics of Warfarin

A Drug-Drug Interaction Study of Warfarin and PA21

Follow on Study From RE-ALIGN

Switching Study From Warfarin to Rivaroxaban

Trial to See if Topical Pennsaid for Knee Pain Affects Coagulation Values in Patients Who Are Also Taking Anticoagulants

Venous Thromboembolism (VTE) Treatment Study in Japanese Pulmonary Embolism (PE) Patients

Venous Thromboembolism (VTE) Treatment Study in Japanese Deep Vein Thrombosis (DVT) Patients

Drug-drug Interaction Study of Tivantinib (ARQ 197) With Omeprazole, S-warfarin, Caffeine, Midazolam, and Digoxin in Cancer Subjects

Autologous Hematopoietic Stem Cell Transplantation in Ischemic Stroke

Genetic Response to Warfarin in Healthy Subjects

Effect of Lacosamide 200 mg Twice a Day (Bid) on Single Dose Warfarin 25 mg in Healthy Males

A Clinical Study of Lyophilized Plasma in Patients on Warfarin

LV Thrombus After Acute AMI: A Randomized Controlled Trial

Use of Activated Recombinant Human Factor VII to Reduce Bleeding Caused by Warfarin Treatment

Fiix-prothrombin Time for Monitoring Warfarin

Warfarine in Unexplained Oligohydramnios

Dexpramipexole and Warfarin Drug Drug Interaction (DDI) Study

Dabigatran Versus Warfarin Anticoagulation Before and After Catheter Ablation for the Treatment of Atrial Fibrillation

Applying Pharmacogenetics to Warfarin Dosing in Chinese Patients

A Trial of Genotype-based Warfarin Initiation in Patients With Mechanical Prosthetic Heart Valve

A Study to Evaluate the Effect of a Single Dose of CNTO 136 (Sirukumab) on CYP450 Enzyme Activities After Subcutaneous Administration in Patients With Rheumatoid Arthritis

Improving Anticoagulation Control in VISN 1

Prolongation of the Interval Between Prothrombin Time Tests in Stable Patients II

Drug Interaction Study of Isavuconazole and Warfarin in Healthy Male Subjects

A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis

Warfarin Versus Aspirin in Patients With Atrial Fibrillation and Chronic Kidney Disease

Explore the Efficacy and Safety of Once-daily Oral Rivaroxaban for the Prevention of Cardiovascular Events in Subjects With Nonvalvular Atrial Fibrillation Scheduled for Cardioversion

Left Atrial Appendage (LAA) Occluders After Catheter Ablation of Atrial Fibrillation

Rhythm Evaluation for AntiCoagulaTion With COntinuous Monitoring

Prospective Study on the Treatment of Unsuspected Pulmonary Embolism in Cancer Patients

Compare VKA vs LMWH in Patients With Anticoagulation Criteria and Episode of Gastrointestinal Bleeding.

Anticoagulation With Rivaroxaban in Cardioversion -The ARC Study

Safety And Efficacy of Low Dose Oral Anticoagulants And Aspirin Therapy

CI(R)CA : Coumadin Interaction With Rofecoxib, Celecoxib and Acetaminophen

Phase I Study to Evaluate the Effect of LDE225 on the Pharmacokinetics of Bupropion and Warfarin in Patients

AStudy To Evaluate Safety And Eficacy Of Apixaban In Japanese Acute Deep Vein Thrombosis (DVT) And Pulmonary Embolism (PE) Patients

Validation of a Novel Dabigatran Based Peri-Operative Bridging Anticoagulation Protocol for Patients on Chronic Warfarin Therapy

A Study of Evacetrapib (LY2484595) and Warfarin in Healthy Participants

Comparative Effectiveness of Oral Anticoagulants

Anticoagulant Utilization Pattern

The Study of Warfarin Maintenance Dose in Chinese Patients

Assessment of International Normalized Ratio (INR) Prolongation in Patients Treated Simultaneously With Warfarin and Cephalosporins

Dabigatran Versus Warfarin After Mitral and/or Aortic Bioprosthesis Replacement and Atrial Fibrillation Postoperatively

Efficacy of Bemiparin Versus Enoxaparin in the Treatment of DVT

Drug-drug Interaction Study With MDV3100 and a Cocktail of Substrates

Risk of Stroke and Silent Cerebrovascular Thromboembolism After Cardioversion of Atrial Fibrillation

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (UK)

Cardiovascular Improvements With MV ASV Therapy in Heart Failure

Optimizing Antithrombotic Care in Patients With AtriaL fibrillatiON and Coronary stEnt (OAC-ALONE) Study

Improving Anticoagulant Therapy Through Warfarin Metabolite Profiling

To Establish a Novel Prototype of Clinical Pharmacy Services by Warfarin Consultation in a Pharmacist Clinic

Prevention of Recurrence After Thrombolysis in Acute Iliofemoral Venous Thrombosis (PRAIS) Study

Short Term Warfarin Therapy for Radiofrequency Catheter Ablation of Atrial Fibrillation

Cognitive Impairment Related to Atrial Fibrillation Prevention Trial

D-Dimer Determined Anticoagulation INTENSITY in Patients With Mechanical Valve Replacement

Drug-drug Interaction Study(Lobeglitazone, Warfarin)

Therapeutic Equivalence Between Branded and Generic WARFArin Tablets in Brazil

Influence of Semaglutide on Pharmacokinetics and Pharmacodynamics of Warfarin and Pharmacokinetics of Metformin in Healthy Subjects

Cost Effectiveness Analysis In Patients With Heart Valve Prosthesis

Rivaroxaban Estimation With Warfarin in Atrial Fibrillation Patients With Coronary Stent Implantation Study (REWRAPS)

Safety and Efficacy Study of LAmbre LAA Closure Device for Treating AF Patients Who Cannot Take Warfarin

Rivaroxaban Versus Warfarin in Acute Ischemic Stroke With Atrial Fibrillation

The Safety and Effectiveness of Warfarin and Dabigatran Prescribed in the Non-Valvular Atrial Fibrillation Population With DoD Healthcare Coverage

Biomarkers and Antithrombotic Treatment in Cervical Artery Dissection - TREAT-CAD

Evaluation of Wound Drainage After Knee or Hip Arthroplasty

The Comparative Safety and Effectiveness of Warfarin and Dabigatran Prescribed in the Non-valvular Atrial Fibrillation Population With Humana Healthcare Coverage

Pharmacogenetic Dosing of Warfarin

Rivaroxaban Compared to Vitamin K Antagonist Upon Development of Cardiovascular Calcification

Validation of International Warfarin Pharmacogenetics Consortium (IWPC) Algorithm in Elderly Patients With Comorbidity

A Trial Investigating the Influence of Oral Semaglutide on the Pharmacokinetics of Lisinopril and Warfarin in Healthy Subjects

Edoxaban vs. Warfarin in Subjects Undergoing Cardioversion of Nonvalvular Atrial Fibrillation (NVAF)

Outpatient Treatment of Low-Risk Venous Thromboembolism With Target Specific Anticoagulant

Sequential Expansion of Comparative Effectiveness of Anticoagulants

Apixaban Versus Warfarin in the Evaluation of Progression of Atherosclerotic Calcification and Vulnerable Plaque

Tapered Warfarin or Interrupted Warfarin With Heparin Bridging for Pacemaker or Defibrillator Implantation

Study Of The Blood Thinner, Apixaban, For Patients Who Have An Abnormal Heart Rhythm (Atrial Fibrillation) And Expected To Have Treatment To Put Them Back Into A Normal Heart Rhythm (Cardioversion)

Personalized Medicine Decision-Making in a Virtual Clinical Setting

Prophylactic Clip Application for Colon Polypectomy in Patients With Anticoagulation

Anticoagulation in AF Ablation and Effects on Neurocognitive Function

CoaguChek XS in Antiphospholipid Antibody Syndrome (APL) Patients

Rivaroxaban in Thrombotic Antiphospholipid Syndrome

Study of the Efficacy, Safety and Tolerability of Low Molecular Weight Heparin vs. Unfractionated Heparin in Stroke

Study of Evacetrapib (LY2484595) and Warfarin in Healthy Participants

Vascular CalcIfiCation and sTiffness Induced by ORal antIcoAgulation

Evaluation of Dual Therapy With Dabigatran vs. Triple Therapy With Warfarin in Patients With AF That Undergo a PCI With Stenting (REDUAL-PCI)

Effect of BIA 9-1067 on the Pharmacokinetics and Pharmacodynamics of Warfarin

Bioequivalence of IVAX Warfarin Tablets and Coumadin Brand Warfarin Tablets in Healthy Volunteers

Hirudin Plus Aspirin in the Secondary Prevention of Cardioembolic Stroke Due to Nonvalvular Atrial Fibrillation

Effects of BI 201335 NA on Cytochrome P450 and P-glycoprotein Activity Using a Probe Drug Cocktail in Healthy Volunteers

Bioavailability of Warfarin After Coadministration With Multiple Doses of BI 1356 Compared to the Bioavailability of Warfarin Alone in Healthy Male Volunteers

The Influence of Preoperative Warfarin Medication on Thromboelastography and Blood Transfusion

Safety of "Ticagrelor+ Warfarin"in Comparison With "Clopidogrel+Aspirin+Warfarin"

Genotype-guided Warfarin Individualized Treatment

Therapy With New Oral Anticoagulants

Apixaban During Atrial Fibrillation Catheter Ablation: Comparison to Vitamin K Antagonist Therapy

Warfarin Prevents Portal Vein Thrombosis in Liver Cirrhotic Patients With Hypersplenism After Laparoscopic Splenectomy

Intracerebral Hemorrhage Due to Oral Anticoagulants: Prediction of the Risk by Magnetic Resonance

Use of Ventavis in Patients With Postembolic Residual Pulmonary Hypertension

Anticoagulation Regimens in Pregnant Patients With Prosthetic Heart Valves

Anticoagulation Regiments in Patients With Prosthetic Heart Valve Thrombosis

Effects of Tipranavir (With Ritonavir) Capsule and Liquid Formulation on Cytochrome P450 and P-glycoprotein Activity in Healthy Volunteers

Antiplatelet Therapy for Patients Undergoing Transcatheter Aortic Valve Implantation

Warfarin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy and Azygoportal Disconnection

A Study to Evaluate the Effects of Multiple Doses of FG-4592 on the Exposure, Safety and Tolerability and Effect of Warfarin in Healthy Subjects

The Effect of BI 187004 on the Pharmacokinetics of Cytochrome P450 Substrates (Caffeine, Warfarin, Omeprazole, Metoprolol and Midazolam) and a P Glycoprotein Substrate (Digoxin)

Study to Evaluate the Effect of Multiple Doses of BIRT 2584 XX Tablets on the Pharmacokinetic Parameters of Warfarin, Omeprazole, Caffeine, and Dextromethorphan in Healthy Male Volunteers

Randomized Controlled Feasibility Trial of the Fearon Algorithm to Improve Management of Unstable Warfarin

Long Term Outcomes of Venous Thromboembolism

INR Control and Atrial Fibrillation in Primary Care in Spain (PAULA)

Apixaban for Early Prevention of Recurrent Embolic Stroke and Hemorrhagic Transformation

Benefit/Risk in Real Life of New Oral Anticoagulants and Vitamin K Antagonists in Patients Aged 80 Years and Over

The Effect of BIA 2-093 on the Steady-state Pharmacodynamic and Pharmacokinetic Profiles of Warfarin

Apixaban for Secondary Prevention of Thromboembolism Among Patients With AntiphosPholipid Syndrome

A Prospective Trial to Assess Cost and Clinical Outcomes of a Clinical Pharmacogenomic Program

Use of Warfarin After the First Trimester in Pregnant Women With APS

RIvaroxaban for Valvular Heart diseasE and atRial Fibrillation Trial -RIVER Trial

Effect of Opicapone at Steady State on Warfarin Pharmacokinetics

Perfusion Computer Tomography: Imaging and Clinical Validation Following Reperfusion Therapy in Acute Ischaemic Stroke

An Observational Cohort Study to Investigate the Risk of Thromboembolic Events in Patients Receiving Kcentra® or Plasma to Reverse Vitamin K Antagonist (VKA) Therapy in the Setting of Acute Major Bleeding

Vitamin K Supplementation in Patients on Hemodialysis

Statin Use in Patients With Acute VTE

Rivaroxaban in Patients With Atrial Fibrillation and Coronary Artery Disease Undergoing Percutaneous Coronary Intervention

Drug-Drug Interaction Potential of Orbactiv (Oritavancin) Co-Administered With Warfarin in Healthy Subjects

ReAl-life Multicentre Survey Evaluating Stroke Prevention Strategies (RAMSES)

Effect of BI 1181181 on Midazolam, Warfarin, Omeprazole and Digoxin

A Genomic Approach to Warfarin Dose Prescription in Admixed Caribbean Hispanics

Uninterrupted Dabigatran Etexilate in Comparison to Uninterrupted Warfarin in Pulmonary Vein Ablation (RE-CIRCUIT)

Blood Donation From Warfarin Users for the Development of POC INR Monitor

Cerebral Microbleeds During NOACs or Warfarin Therapy in NVAF Patients With Acute Ischemic Stroke (CMB-NOW)

Self-management of Anticoagulation Treatment

Hemorrhage Following Small Polyp Resection in the Colon in Anticoagulated Patients

Rivaroxaban Versus Warfarin in the Evaluation of Progression of Coronary Calcium

The Effect of Medication Timing on Anticoagulation Stability in Users of Warfarin: The "INRange" RCT

Prospective Evaluation of an Extended Interval of INR Follow-up in a VA Anticoagulation Service

Pharmacokinetic Study to Evaluate the Effect of a Single Dose of Guselkumab (CNTO 1959) on CYP 450 Enzyme Activities After Subcutaneous Administration in Participants With Psoriasis

The Effect of Anticoagulation After Endoscopic Therapy in Cirrhotic Patients With Portal Vein Thrombosis

A Phase I, Multi-center, Open Label, Drug-drug Interaction Study to Assess the Effect of Ceritinib on the Pharmacokinetics of Warfarin and Midazolam in Patients With ALK-positive Advanced Tumors

A Drug Drug Interaciton Study of Imrecoxib and Warfarin in Healthy Volunteers

FFP Versus PCC in Intracranial Hemorrhage

An Open Label, Single Dose, Three Part Study to Assess the Effects of Rolapitant (2 mg/mL IV Solution) on the Pharmacokinetics of Digoxin; Sulfasalazine; and the Cooperstown Cocktail (Midazolam, Omeprazole, Warfarin, Caffeine, and Dextromethorphan in Healthy Subjects

Apixaban in Patients Who Undergo CIED Procedure- Randomized Pilot Study

A Study to Evaluate the Safety of a Single Intravenous (IV) Dose of Orbactiv (Oritavancin) in Participants on Chronic Warfarin Therapy Being Treated For Acute Bacterial Skin and Skin Structure Infection (ABSSSI)

The AHEAD Study: Monitoring Anticoagulated Patients Who Suffer Head Injury

Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients

Evaluate the Pharmacokinetics of Warfarin When Coadministered With PEX168 in Healthy Adult Subjects

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Practice (Sweden)

Model-based Versus Traditional Warfarin Dosing in Children

Addressing Real-world Anticoagulant Management Issues in Stroke

LAA Excision With AF Ablation Versus Oral Anticoagulants for Secondary Prevention of Stroke

TIPS vs Endoscopic Therapy for Variceal Rebleeding in Cirrhotic Patients With Portal Vein Thrombosis

Left Atrial Appendage Closure Compared to Standard Antiplatelet Therapy in Patients With AF Who Underwent PCI

Adherence of Apixaban and Warfarin in Patients With Arterial Fibrillation in Real-world Setting in Sweden

Study of Statin for Reduction of Postoperative Paroxysmal Atrial Fibrillation

XENITH: Rivaroxaban for Pulmonary Embolism Managed With Catheter Directed Thrombolysis

Immunologic Effects of Supplemental Monosaccharide and Nucleoside Derivatives in Patients With Inherited Disorders of Glycosylation

Tecarfarin Anti-Coagulation Trial (TACT)

Anticoagulation for Non-occlusive Portal Vein Thrombosis in Patients With Liver Cirrhosis

Drug Interaction Study of Warfarin and MT-3995

A Drug Interaction Study of Lanabecestat (LY3314814) and Warfarin in Healthy Participants

Pleotropic Effect of New Oral Anticoagulants

EdoxabaN or Warfarin Therapy In Device Procedures in Patients With Non-Valvular Atrial Fibrillation

Fixed-dose Activated Versus Variable-dose Inactivated Prothrombin Complex Concentrate for Warfarin-associated Major Bleed

Drug Interaction Study of GBT440 With Caffeine, S-warfarin, Omeprazole, and Midazolam in Healthy Subjects

Assessment of 2012 Bioequivalence Standards for Warfarin

A Study to Evaluate the Effect of Multiple Doses of JNJ-56021927 on the Pharmacokinetics of Multiple Cytochrome P450 and Transporter Substrates in Participants With Castration-Resistant Prostate Cancer

Evaluation of a Pharmacogenetic-based Warfarin Dosing Algorithm in Patients

Using Artificial Intelligence to Measure and Optimize Adherence in Patients on Anticoagulation Therapy.

Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation

Effect on Vascular Calcification of Replacing Warfarin by Rivaroxaban With or Without VitK2 in Hemodialysis Patients

Atrial Fibrillation Patient Preference Study

A Study to Assess the Effect of Multiple-Dose Administration of JNJ-42847922 on Midazolam and Warfarin in Healthy Participants

A Drug-drug Interaction Study Between GLPG1205 and a Cocktail of CYP450 Substrates in Healthy Male Subjects

The Effect of Anticoagulation in Cirrhotic Patients With Portal Vein Thrombosis：A Multicenter RCT

Length of Stay in NVAF Patients Hospitalized and Initiated With Dabigatran or Warfarin in Japan

What is the Optimal antiplatElet and Anticoagulant Therapy in Patients With Oral Anticoagulation Undergoing revasculariSaTion 2.

Study of the Effects of ITCA 650 on Gastric Emptying and Interaction of ITCA 650 on 4 Commonly Studied Drugs

The Efficacy and Safety Study of Dabigatran and Warfarin to Non-valvular Atrial Fibrillation Patients

Open Label, Drug-Drug Interaction (DDI) Study of Dupilumab (REGN668/SAR231893) in Patients With Moderate to Severe Atopic Dermatitis (AD)

Evaluation of Hospital Readmissions Among Hospitalized Non-valvular Atrial Fibrillation (NVAF) Patients in the US

On-X Aortic Prosthetic Heart Valve Low Dose Warfarin Post Approval Clinical Registry Study

A Study of Abemaciclib in Participants With Cancer That is Advanced or Has Spread to Another Part(s) of the Body

Frequency of Reduced Leaflet Motion After Surgical Aortic Valve Replacement and Transcatheter Aortic Valve Replacement.

AtriClip® Left Atrial Appendage Exclusion Concomitant to Structural Heart Procedures (ATLAS)

Comparison Between Xarelto Versus Warfarin in the Recanalization Rate of Deep Venous Thrombosis in Patients Legs.

Prospective Trial of a Validated Algorithm for Warfarin Dosing

The Pharmacogenetics of Optimal Warfarin Therapy in Chinese Patients After Heart Valve Replacement.

Drug-Drug Interaction Study to Assess the Effects of Multiple-Dose Administration of K-877 on the Pharmacodynamics and the Pharmacokinetics of Multiple-Dose Administration of Warfarin in Healthy Adult Volunteers

Improving Quality of Care - Managing Atrial Fibrillation Through Care Teams and Health Information Technology

Pharmacokinetic Drug-Drug Interaction Study of Rucaparib

Anticoagulation in Cancer Related Stroke

Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer

Registry Of Acute meDical Emergencies in Brazil

Real-World Comparative Observational Study in Non-Valvular Atrial Fibrillation Patients Using Oral Anticoagulants

Patient Training About the Safety of Warfarin Therapy

Excessive Warfarin Anticoagulation - Causes and Consequences

Assessing the Ability of Warfarin Treated Patients to Predict Their INR

Pediatric High-Risk Deep Venous Thrombosis Lytic Outcomes Trial

Replication Of An Early Evaluation Of 30-Day Readmissions Among Nonvalvular Atrial Fibrillation Patients Treated With Dabigatran, Rivaroxaban, Apixaban, or Warfarin In The U.S

This Study Tests the Effect of Risankizumab on the Metabolism in the Liver of Five Additional Drugs to Study Possible Drug Interactions in Patients With Psoriasis With or Without Psoriatic Arthritis

Patient-Centered Anticoagulation Self-Monitoring in Minority Patients

Coordination of Oral Anticoagulant Care at Hospital Discharge

Effect of BIA 3-202 on the Pharmacokinetics and Pharmacodynamics of Warfarin

A Pharmacokinetics, Pharmacodynamics and Safety Study of Warfarin in Combination With Tamiflu (Oseltamivir)

The Effect of Voltaren-ophtha 0.1% Eye Drops on INR Levels (International Normalized Ratio) in Patients Taking Warfarin

Interaction of BI 425809 With Midazolam, Warfarin, Omeprazole and Digoxin

Comparison Study of Drugs for Symptom Control and Complication Prevention of Atrial Fibrillation (AF) (Code-AF Trial)

Effect of Pradaxa vs Warfarin on Bone Mass and Bone Turnover Markers

Oral Anticoagulant Discontinuation, Adherence Patterns, Hospitalizations and Costs in Non-Valvular Atrial Fibrillation (NVAF) Patients

Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE)

Bleeding Frequency Under Anticoagulant Treatment in Pulmonary Hypertension

Quality of Anticoagulation With Warfarin in Patient With Atrial Fibrillation for Secondary Stroke Prevention in Korea

Comparative Effectiveness of Pulmonary Embolism Prevention After Hip and Knee Replacement

Aortic Calcification and Vitamin K Antagonists

INVestIgation of rheumatiC AF Treatment Using Vitamin K Antagonists, Rivaroxaban or Aspirin Studies, Non-Inferiority

Direct Oral Anticoagulants and Venous Thromboembolism

Prevention of Non-Surgical Bleeding by Management of HeartMate II Patients Without Antiplatelet Therapy

TIPS for Variceal Rebleeding in Cirrhotic Patients With Occlusive Portal Vein Thrombosis and CTPV

Self-management of Anticoagulation Treatment

The Educational Effectiveness for Atrial Fibrillation Patients Under Warfarin Treatment

Dabigatran as an Alternative Anticoagulant in Patients With Left Ventricular Assist Device (LVAD)

Apixaban Versus Warfarin for the Management of Post-operative Atrial Fibrillation

A Clinical Trial Comparing Efficacy and Safety of Dabigatran Etexilate With Warfarin in Patients With Cerebral Venous and Dural Sinus Thrombosis (RE-SPECT CVT)

ORal anticoaGulants in diAbetic and Nondiabetic Patients With nOn-valvular Atrial fibrillatioN (ORGANON)

Trial to Evaluate Anticoagulation Therapy in Hemodialysis Patients With Atrial Fibrillation

Edoxaban Treatment Versus Vitamin K Antagonist (VKA) in Patients With Atrial Fibrillation (AF) Undergoing Catheter Ablation

AMPLATZER™ Cardiac Plug Observational Post-Approval Study

Pharmacogenomics of Warfarin in Hispanics and Latinos

Pradaxa or Warfarin for Prevention of Recurrent VTE in Patients With Angiographically Confirmed Acute Massive Pulmonary Embolism undergoIng Endovascular Mechanical Fragmentation and Thrombolytic Therapy

A Study of the Safety and Pharmacokinetics of Apixaban Versus Vitamin K Antagonist (VKA) or Low Molecular Weight Heparin (LMWH) in Pediatric Subjects With Congenital or Acquired Heart Disease Requiring Anticoagulation

Apixaban Versus Warfarin in Patients With Left Ventricular Thrombus

Dabigatran Versus Conventional Treatment for Prevention of Silent Cerebral Infarct in Atrial Fibrillation Associated With Valvular Disease

MultiCenter expeRience in AFib Patients Treated With OAC (CRAFT)

A Study of Ixekizumab in Participants With Plaque Psoriasis

Validation of Predictors of OAC Initiation Using EMR Data

Prevalence of Post-Thrombotic Syndrome in Deep-Vein Thrombosis (DVT) Patients Treated With Dabigatran

A Study to Evaluate the Effect of Oral Doses of JNJ-54175446 on the Inhibition of Cytochrome P450 CYP3A4, CYP2C9, CYP1A2 and CYP2D6 Activity and the Induction of CYP2B6 and CYP2C19 Activity Using a Multiple Probe Substrate Cocktail in Healthy Subjects

Impact of Anticoagulation Therapy on the Cognitive Decline and Dementia in Patients With Non-Valvular Atrial Fibrillation

Optimal Antithrombotic Therapy in Ischemic Stroke Patients with Non-Valvular Atrial Fibrillation and Atherothrombosis

Fixed Versus Variable Dosing of 4-factor Prothrombin Complex Concentrate for Emergent Warfarin Reversal

MAGENTUM 1 HeartMate 3 LVAS: A Single Center Prospective Controlled Study (MAGENTUM 1)

Clinical and Economic Outcomes of Oral Anticoagulants in Non-valvular Atrial Fibrillation

A Pilot Study of Edoxaban in Patients With Non-Valvular Atrial Fibrillation and Left Atrial Appendage Closure

Anticoagulation Therapy in the Very Old

Evaluation of the Intra- and Post- Operative Bleeding After Periodontal Debridement in Direct Anticoagulant Patients

Intra- and Post- Operative Bleeding After Simple Dental Extraction in Direct Oral Anticoagulant Therapy

Impact of Telephone Follow-up in Patient's Health-related Quality of Life That Use Warfarin

Improving Stroke Prevention in Atrial Fibrillation Through Pharmacist Prescribing

Multi-Center Single Arm Trial to Determine The Effectiveness of Warfarin Therapy Duration For Heparin-Induced Thrombocytopenia (HIT)

Start or STop Anticoagulants Randomised Trial (SoSTART)

Study of Rivaroxaban for CeREbral Venous Thrombosis

Pharmacogentic Screening of Coumarine Based Oral Anticoagulant Using Next Generation Seguencer

Tooth Extraction in Patients With Atrial Fibrillation in Use of New Oral Anticoagulants

Dabigatran in Patients With Atrial Fibrillation and Mitral Biological Prostheses

The Appropriate Anticoagulation Duration for Chronic Obstructive Pulmonary Disease With Pulmonary Thromboembolism

A Real-World Comparison of Safety and Effectiveness of Novel Oral Anti-Coagulant (NOAC) Naïve and Warfarin Naïve Non-Valvular Atrial Fibrillation (NVAF) Patients With Medicare Advantage Coverage

Comparison of the Efficacy of Rivroxaban to Coumadin( Warfarin ) in Cerebral Venous Thrombosis

Comparison of Oral Anticoagulants for Extended VEnous Thromboembolism

Assessment of The Effect of Apixaban in AF

Pharmacist Interventions in Rural Elderly Warfarin Patients

The Efficacy and Safety of Dabigatran Etexilate for the Treatment of Cerebral Venous Thrombosis

Apixaban Versus Warfarin in Patients With Left Ventricular (LV) Thrombus

Optimal Antithrombotic Therapy for ACS Patients Concomitant With AF and Implanted With New-generation DES (OPTIMA-3, 4)

Assess the Influence of Cenobamate on the PK of Cytochrome P450 (CYP) Probe Drugs As a Means of Predicting Drug-drug Interactions

Explore the Efficacy and Safety of edoxabaN in Patients After Heart Valve Repair or Bioprosthetic vaLve Replacement (ENAVLE Trial)

A Study To Test The Effect Of Apatinib On P450 Enzymes

Comparative Effectiveness and Safety Between Warfarin and Dabigatran

Medical Need of OAC Reversal

Social-software iMproving wARfarin Therapy

The DARE Warfarin CER Study

D-dimer In Patients With atRial Fibrillation rEceiving antiCoagulation Therapy

Anticoagulation Length of ThErapy and Risk of New Adverse evenTs In Venous thromboEmbolism Study

Patient-Centred Care for Warfarin Management: A Pilot Study to Transition Care to High Risk Patients

Thromboprophylaxis in Patients Undergoing Orthopedic Surgeries; Comparison Between Rivaroxaban and Enoxaparin

WATCHMAN for Second Prevention of Stroke (WASPS)

Study to Compare Pharmacokinetics & Pharmacodynamics of Warfarin & Esmolol in the Absence & Presence of MEDI0382

A Study to Evaluate the Effect of Ustekinumab on Cytochrome P450 Enzyme Activities Following Induction and Maintenance Dosing in Participants With Active Crohn's Disease or Ulcerative Colitis

Clinical Outcomes Among Non-valvular Atrial Fibrillation Patients With Renal Dysfunction

A Study to Evaluate the Effect of Multiple Doses of CC-90001 on the Pharmacokinetics of Omeprazole, Midazolam, Warfarin, Rosuvastatin, Metformin, Digoxin, and Nintedanib in Healthy Adult Subjects

Rivaroxaban vs Warfarin for SPAF in Multi-morbid Patients

Edoxaban for Prevention of Blood Vessels Being Blocked by Clots (Thrombotic Events) in Children at Risk Because of Cardiac Disease

Optimized Antithrombotic Therapy of Acute Myocardial Infarction With Left Ventricular Mural Thrombus

Drug-drug Interaction Study to Evaluate the Effect of ISIS 681257 on Warfarin

Analysis of the Potential Savings of Rivaroxaban Events Versus Vitamin K Antagonists Events

Left Atrial Appendage CLOSURE in Patients With Atrial Fibrillation Compared to Medical Therapy

Vascular Boot Warming Program After Acute Deep Vein Thrombosis (DVT) ± Pulmonary Embolism (PE)

Assessment of Coagulation Factor Levels in Left Ventricular Device (LVAD )Patients Following Temporary Warfarin Reversal With Four Factor Prothrombin Complex Concentrate (4F-PCC)

Genotype-guided Versus Standard for Warfarin Dosing

Acute Mesenteric Venous Thrombosis.. in Assiut University Hospital Management Controversies

The Prevalence of Sub Optimal Anti Coagulation

Rivaroxaban Once Daily Versus Dose-adjusted Vitamin K Antagonist on the Biomarkers in Acute Decompensated Heart Failure and Atrial Fibrillation (ROAD HF-AF)

Study to Describe Risk of Bleeding in Patients Depending on the Different Anticoagulant Therapy They Are on for Atrial Fibrillation (AF)